首页> 外国专利> EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR

EXTRACELLULAR MATRIX/METASTASIS MODIFER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR

机译:细胞外基质/转移性肿瘤基因,用于预防或抑制肿瘤的转移或生长以及肿瘤的表征

摘要

Disclosed are methods involving the administration of an extracellular matrix (ECM)/metastasis modifier gene, e.g., Anakin, Necdin, CentaurinD3 (CentD3), Csf1r, Brd4, Pi16, and Luc7l, for the prevention or inhibition of metastasis or of tumor growth. Further disclosed are methods of characterizing a tumor or cancer in a subject comprising detecting (i) a single nucleotide polymorphism (SNP) in an Anakin gene or a Brd4 gene of the subject, (ii) an amino acid substitution in an Anakin protein in the subject, or (iii) a level of expression of an Anakin gene or a Brd4 gene in the subject. Methods of screening a compound for anti-cancer activity and use of a compound with anti-cancer activity for the preparation of a medicament to treat or prevent cancer in a subject are also disclosed. Also disclosed is a method of inhibiting Sipa-1 in a subject.
机译:公开了涉及施用细胞外基质(ECM)/转移修饰基因例如Anakin,Necdin,CentaurinD3(CentD3),Csf1r,Brd4,Pi16和Luc71的方法,以预防或抑制转移或肿瘤生长。还公开了表征受试者中的肿瘤或癌症的方法,其包括检测(i)受试者的Anakin基因或Brd4基因中的单核苷酸多态性(SNP),(ii)所述受试者中Anakin蛋白中的氨基酸取代。 (iii)Anakin基因或Brd4基因在受试者中的表达水平。还公开了筛选具有抗癌活性的化合物的方法以及具有抗癌活性的化合物在制备用于治疗或预防受试者中的癌症的药物中的用途。还公开了在受试者中抑制Sipa-1的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号